Skip to main content
Clinical Trials/NCT01222208
NCT01222208
Completed
Not Applicable

Oral Versus Parenteral Perioperative Nutrition Support to Improve Protein Balance: Stable Isotope Study in Colorectal Surgical Patients

McGill University Health Centre/Research Institute of the McGill University Health Centre1 site in 1 country20 target enrollmentMarch 2011
ConditionsColon Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colon Cancer
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Enrollment
20
Locations
1
Primary Endpoint
Whole body protein balance
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

A prospective, randomized controlled study, using stable isotope methodology, is proposed to determine whether an oral nutrition support regimen, containing pressurized whey protein and glucose, is more effective at normalizing the metabolic response to surgery than a standard peripheral parenteral nutrition (PPN) support regimen, containing amino acids and glucose, in colorectal surgical patients studied before and after surgery. The effectiveness of the nutrition support regimens will be determined by: whole body protein balance, synthesis rates of hepatic secretory proteins, resting energy expenditure and substrate utilization, as well as circulating metabolites concentrations.

Registry
clinicaltrials.gov
Start Date
March 2011
End Date
November 2011
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Responsible Party
Principal Investigator
Principal Investigator

Franco Carli

Dr. Franco Carli

McGill University Health Centre/Research Institute of the McGill University Health Centre

Eligibility Criteria

Inclusion Criteria

  • The American Society of Anesthesiologists' (ASA) class 1 to 3
  • Colorectal surgery for non-metastatic disease (including right, transverse, left, sigmoid, subtotal, total, and hemicolectomy)
  • Nutrition status: 18.5 \< body mass index \< 30 kg/m2, stable weight over the preceding three months (\< 10% body weight loss), serum albumin \> 35g/l

Exclusion Criteria

  • History of hepatic failure (Child-Pugh score A-C and transaminases outside the normal range)
  • Renal impairment (Serum Creatinine outside normal range)
  • Cardiac failure (New York Heart Association (NYHA) classes I-IV)
  • Hepatic, Renal, Cardiac transplant
  • Endocrine disorders: diabetes type I \& II, hyper and hypothyroidism
  • Active inflammatory bowel or diverticular disease (Crohn's Disease, Ulcerative Colitis)
  • Musculoskeletal or neuromuscular disease
  • Anemia defined as hematocrit \< 30, hemoglobin \< 10 g/dl, albumin \< 25 mg/dl
  • Previous spine surgery or scoliosis limiting use of epidural
  • Use of Steroids

Outcomes

Primary Outcomes

Whole body protein balance

Time Frame: 1 year

Whole body protein balance (the difference between protein synthesis and protein breakdown) as assessed by the kinetics of a stable, non-radioactive, isotope tracer infusion of L-\[1-13C\] leucine

Secondary Outcomes

  • Synthesis rates of hepatic secretory proteins(1 year)

Study Sites (1)

Loading locations...

Similar Trials